Status: Recruiting
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive prevention strategy among patients with high risk focused on implementation of evidence-based HF preventive therapies.
Participants needed: 300
Trial details
Biological sex: AllType: InterventionalSponsor: University of Texas Southwestern Medical CenterUpdated: Feb 27, 2026Locations: 1
Eligibility criteria
Primary Care Provider that sees diabetes patients in clinic
Provider does not see patients with Diabetes